S&P 500   5,067.59 (-0.04%)
DOW   38,890.56 (-0.46%)
QQQ   436.73 (+0.04%)
AAPL   180.87 (-0.16%)
MSFT   405.66 (-0.46%)
META   483.77 (+0.42%)
GOOGL   138.08 (+0.37%)
AMZN   174.06 (-0.38%)
TSLA   202.72 (+1.66%)
NVDA   786.33 (-0.58%)
NIO   5.79 (+2.48%)
AMD   176.74 (+0.41%)
BABA   77.28 (+1.01%)
T   16.63 (+0.18%)
F   12.07 (+1.00%)
MU   90.99 (+1.71%)
CGC   3.55 (+2.31%)
GE   153.29 (-0.96%)
DIS   108.42 (+0.69%)
AMC   4.70 (+5.62%)
PFE   27.01 (-0.63%)
PYPL   59.75 (+0.71%)
XOM   104.50 (+0.24%)
S&P 500   5,067.59 (-0.04%)
DOW   38,890.56 (-0.46%)
QQQ   436.73 (+0.04%)
AAPL   180.87 (-0.16%)
MSFT   405.66 (-0.46%)
META   483.77 (+0.42%)
GOOGL   138.08 (+0.37%)
AMZN   174.06 (-0.38%)
TSLA   202.72 (+1.66%)
NVDA   786.33 (-0.58%)
NIO   5.79 (+2.48%)
AMD   176.74 (+0.41%)
BABA   77.28 (+1.01%)
T   16.63 (+0.18%)
F   12.07 (+1.00%)
MU   90.99 (+1.71%)
CGC   3.55 (+2.31%)
GE   153.29 (-0.96%)
DIS   108.42 (+0.69%)
AMC   4.70 (+5.62%)
PFE   27.01 (-0.63%)
PYPL   59.75 (+0.71%)
XOM   104.50 (+0.24%)
S&P 500   5,067.59 (-0.04%)
DOW   38,890.56 (-0.46%)
QQQ   436.73 (+0.04%)
AAPL   180.87 (-0.16%)
MSFT   405.66 (-0.46%)
META   483.77 (+0.42%)
GOOGL   138.08 (+0.37%)
AMZN   174.06 (-0.38%)
TSLA   202.72 (+1.66%)
NVDA   786.33 (-0.58%)
NIO   5.79 (+2.48%)
AMD   176.74 (+0.41%)
BABA   77.28 (+1.01%)
T   16.63 (+0.18%)
F   12.07 (+1.00%)
MU   90.99 (+1.71%)
CGC   3.55 (+2.31%)
GE   153.29 (-0.96%)
DIS   108.42 (+0.69%)
AMC   4.70 (+5.62%)
PFE   27.01 (-0.63%)
PYPL   59.75 (+0.71%)
XOM   104.50 (+0.24%)
S&P 500   5,067.59 (-0.04%)
DOW   38,890.56 (-0.46%)
QQQ   436.73 (+0.04%)
AAPL   180.87 (-0.16%)
MSFT   405.66 (-0.46%)
META   483.77 (+0.42%)
GOOGL   138.08 (+0.37%)
AMZN   174.06 (-0.38%)
TSLA   202.72 (+1.66%)
NVDA   786.33 (-0.58%)
NIO   5.79 (+2.48%)
AMD   176.74 (+0.41%)
BABA   77.28 (+1.01%)
T   16.63 (+0.18%)
F   12.07 (+1.00%)
MU   90.99 (+1.71%)
CGC   3.55 (+2.31%)
GE   153.29 (-0.96%)
DIS   108.42 (+0.69%)
AMC   4.70 (+5.62%)
PFE   27.01 (-0.63%)
PYPL   59.75 (+0.71%)
XOM   104.50 (+0.24%)
OTCMKTS:PTCHF

PureTech Health (PTCHF) Stock Price, News & Analysis

$2.67
+0.02 (+0.57%)
(As of 02/26/2024 12:35 PM ET)
Today's Range
$2.67
$2.70
50-Day Range
$1.87
$2.85
52-Week Range
$1.69
$3.10
Volume
243 shs
Average Volume
39,058 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PTCHF stock logo

About PureTech Health Stock (OTCMKTS:PTCHF)

PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies. It is also developing LYT-300, an oral allopregnanolone, currently completed Phase 1 stage, to treat depression, anxiety, and related indications; and LYT-310, an oral cannabidiol, currently under preclinical stage, to treat epilepsies and other neurological indications. In addition, the company is developing LYT-503/IMB-150, a non-opioid inflammation targeted disease immunomodulation for the potential treatment of interstitial cystitis, or bladder pain syndrome; and Glyph technology platform, a lymphatic-targeting chemistry platform, which leverages the body's natural lipid absorption and transports the process to orally administer drugs via the lymphatic system. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

PTCHF Stock Price History

PTCHF Stock News Headlines

PureTech Health plc (PTCHF)
PureTech Year End Update and Outlook for 2024
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
PureTech Health PLC PRTC
Results of PureTech's Annual General Meeting
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Full Year 2023 PureTech Health PLC Earnings Call
PRTC.L - | Stock Price & Latest News | Reuters
PureTech Health plc (PRTC.L)
See More Headlines
Receive PTCHF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:PTCHF
Fax
N/A
Employees
111
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Ms. Daphne Zohar (Age 53)
    Founder, CEO & Executive Director
    Comp: $1.01M
  • Dr. Bharatt M. Chowrira J.D. (Age 59)
    Ph.D., President, Secretary, Chief Business Finance & Operating Officer and Executive Director
    Comp: $800.55k
  • Dr. Robert S. Langer Jr. (Age 75)
    Ph.D., Co-Founder & Non-Executive Director
    Comp: $145k
  • Dr. David R. Elmaleh Ph.D. (Age 76)
    Co-Founder & Senior Advisor
  • Ms. Allison Mead Talbot
    Head of Communications & Investor Relations
  • Mr. Spencer Ball
    Senior Vice President of Human Resources
  • Dr. Eric Elenko Ph.D. (Age 51)
    Chief Innovation & Strategy Officer
  • Ms. Aleksandra Filipovic M.D.
    Ph.D., Head of Oncology
  • Ms. Cheryl Murphy Ph.D.
    Head of Grants Management & Strategy
  • Ms. Anita Terpstra J.D.
    Ph.D., Senior VP & Head of Intellectual Property














PTCHF Stock Analysis - Frequently Asked Questions

How have PTCHF shares performed in 2024?

PureTech Health's stock was trading at $2.38 at the beginning of the year. Since then, PTCHF shares have increased by 12.0% and is now trading at $2.6650.
View the best growth stocks for 2024 here
.

How do I buy shares of PureTech Health?

Shares of PTCHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PTCHF) was last updated on 2/27/2024 by MarketBeat.com Staff